PL2774991T3 - System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznych - Google Patents
System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznychInfo
- Publication number
- PL2774991T3 PL2774991T3 PL13001491T PL13001491T PL2774991T3 PL 2774991 T3 PL2774991 T3 PL 2774991T3 PL 13001491 T PL13001491 T PL 13001491T PL 13001491 T PL13001491 T PL 13001491T PL 2774991 T3 PL2774991 T3 PL 2774991T3
- Authority
- PL
- Poland
- Prior art keywords
- diagnosis
- treatment
- delivery system
- drug delivery
- neurological disorders
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22071—Demonstrated in vivo effect
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2013/000656 WO2013131644A1 (en) | 2012-03-06 | 2013-03-06 | A novel drug delivery system based on jcv-vlp |
| EP13001491.3A EP2774991B1 (en) | 2013-03-06 | 2013-03-22 | Drug delivery system for use in the treatment or diagnosis of neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2774991T3 true PL2774991T3 (pl) | 2018-05-30 |
Family
ID=47915420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13001491T PL2774991T3 (pl) | 2013-03-06 | 2013-03-22 | System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznych |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP2774991B1 (enExample) |
| CY (1) | CY1120278T1 (enExample) |
| HR (1) | HRP20180361T1 (enExample) |
| LT (1) | LT2774991T (enExample) |
| NO (1) | NO2774991T3 (enExample) |
| PL (1) | PL2774991T3 (enExample) |
| SI (1) | SI2774991T1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3031821A1 (en) * | 2014-12-08 | 2016-06-15 | Life Science Inkubator | polyomavirus VLPs with a fusion protein |
| EP3031820A1 (en) | 2014-12-08 | 2016-06-15 | Life Science Inkubator | JC Polyomavirus VLP (virus-like particle) with a targeting peptide |
| RU2682966C1 (ru) * | 2018-03-20 | 2019-03-25 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Комбинации буспирона для лечения головокружения |
| CN111323527B (zh) * | 2018-12-13 | 2022-12-02 | 湖南德米特仪器有限公司 | 一种用复合二维液相色谱同时测定多种精神药物的方法 |
| CN112137994B (zh) * | 2020-09-15 | 2022-10-14 | 中山大学 | 小分子化合物在制备抗丝状病毒药物中的应用 |
| CN115317614B (zh) * | 2022-10-14 | 2022-12-27 | 暨南大学 | Adk抑制剂在制备治疗脊髓损伤的药物中的应用 |
| AU2023383549A1 (en) | 2022-11-17 | 2025-06-05 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| CN117442618B (zh) * | 2023-10-23 | 2025-11-14 | 国科大杭州高等研究院 | 化合物ly2940094在制备治疗中枢神经系统脱髓鞘疾病药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19543553B4 (de) | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
| EP0977596B1 (en) | 1997-04-26 | 2004-01-21 | Rpms Technology Limited | Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells |
| DE10131145B4 (de) * | 2001-06-28 | 2005-07-14 | Innovent E.V. | Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen |
| EP2036980A1 (de) | 2007-09-14 | 2009-03-18 | Gruber, Jens | Herabregulation der Genexpression mittels Nukleinsäure-beladener virusähnlicher Partikel |
| WO2010090757A1 (en) * | 2009-02-05 | 2010-08-12 | Biogen Idec Ma Inc. | Methods for the detection of jc polyoma virus |
-
2013
- 2013-03-22 NO NO13001491A patent/NO2774991T3/no unknown
- 2013-03-22 EP EP13001491.3A patent/EP2774991B1/en active Active
- 2013-03-22 LT LTEP13001491.3T patent/LT2774991T/lt unknown
- 2013-03-22 EP EP17205393.6A patent/EP3312283A1/en not_active Withdrawn
- 2013-03-22 PL PL13001491T patent/PL2774991T3/pl unknown
- 2013-03-22 SI SI201330957T patent/SI2774991T1/en unknown
-
2018
- 2018-02-28 CY CY20181100252T patent/CY1120278T1/el unknown
- 2018-02-28 HR HRP20180361TT patent/HRP20180361T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT2774991T (lt) | 2018-03-26 |
| HRP20180361T1 (hr) | 2018-04-20 |
| EP2774991B1 (en) | 2017-12-06 |
| EP3312283A1 (en) | 2018-04-25 |
| SI2774991T1 (en) | 2018-04-30 |
| EP2774991A1 (en) | 2014-09-10 |
| CY1120278T1 (el) | 2019-07-10 |
| NO2774991T3 (enExample) | 2018-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| PT3811943T (pt) | Composto para uso no tratamento de distúrbios oculares | |
| PL2968218T3 (pl) | Skojarzenie do leczenia choroby parkinsona | |
| GB2492487B (en) | Cannabinoids for use in the treatment of neurodegenerative diseases or disorders | |
| EP2968881A4 (en) | APPARATUS, SYSTEMS AND METHODS FOR BRAIN MEDICATION ADMINISTRATION FOR TREATING NEUROLOGICAL CONDITIONS | |
| EP2890440A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES | |
| IL237649B (en) | Polymer meters drug for use in the prevention, diagnosis and/or treatment of diseases of the joint | |
| LT2838539T (lt) | Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui | |
| LT2774991T (lt) | Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai | |
| SMT202000164T1 (it) | Antagonisti del recettore cannabinoide cb1 per uso nel trattamento di malattie associate con anomalie dendritiche neuronali | |
| IL240931A0 (en) | History 3 - Phenylpropylamine is converted to the treatment of eye diseases and disorders | |
| PL2764881T3 (pl) | System leczenia medycznego | |
| PT2810599T (pt) | Sistema de estimulação elétrica para o tratamento da apneia do sono | |
| IL238027A0 (en) | 2-phenyl-5-heterocyclyl-tetrahydro-h2-pyran-3-amine compounds for use in the treatment of diabetes and related disorders | |
| HUE038580T2 (hu) | Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra | |
| IL235058A0 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| HUS2000020I1 (hu) | Ciklezonid a légúti betegségek kezelésére lovaknál | |
| EP3177304A4 (en) | Therapeutic nanoparticles for accumulation in the brain | |
| LT3307277T (lt) | Viengrandžiai oligonukleotidai, skirti naudoti mediciniškai gydant odos sutrikimus | |
| IL246855A0 (en) | Materials for use in the treatment of retinitis | |
| IL257983A (en) | Improved transport of drugs into the brain | |
| PL2861568T3 (pl) | Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca | |
| IL244435A0 (en) | Fidotimide for use in the treatment of diseases associated with inflammation | |
| PL3352777T3 (pl) | Engrailed do stosowania w leczeniu uszkodzenia dna u pacjentów cierpiących na chorobę parkinsona | |
| GB201320506D0 (en) | Cyclic amino compounds for the use in the treatment of cardiac disorders |